Lack of association between serum levels of 25-hydroxyvitamin D and the subsequent risk of prostate cancer in Finnish men.
Faupel-Badger
Jessica M
JM
Cancer Prevention Fellowship Program, Division of Cancer Prevention and Mammary Biology and Tumorigenesis Laboratory, National Cancer Institute, 37 Convent Drive, Building 37, Room 1106, Bethesda, MD 20892-4254, USA. badgerje@mail.nih.gov
Diaw
Lena
L
Albanes
Demetrius
D
Virtamo
Jarmo
J
Woodson
Karen
K
Tangrea
Joseph A
JA
D000367:Age Factors; D000368:Aged; D016022:Case-Control Studies; D004311:Double-Blind Method; D005387:Finland; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000097:blood* / Q000517:prevention & control; D012307:Risk Factors; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood; D014815:Vitamins / Q000627:therapeutic use; D024502:alpha-Tocopherol / Q000627:therapeutic use; D019207:beta Carotene / Q000627:therapeutic use
D014815:Vitamins; D019207:beta Carotene; D014807:Vitamin D; C104450:25-hydroxyvitamin D; D024502:alpha-Tocopherol